id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1996-N-0028-0384,FDA,FDA-1996-N-0028,"Tab 1 - ""No Material Submitted"" - [American Herbal Pharmacopeia - Comment] - re FDA-1996-N-0028-0383",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-09T05:00:00Z,2008,12,,,2009-10-29T19:13:12Z,,0,0,09000064804fbbe7
FDA-1996-N-0028-0386,FDA,FDA-1996-N-0028,"Tab 3 - ""No Material Submitted"" - [American Herbal Pharmacopeia - Comment] - re FDA-1996-N-0028-0383",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-09T05:00:00Z,2008,12,,,2009-10-29T19:14:59Z,,0,0,09000064804fbbd1
FDA-1996-N-0028-0385,FDA,FDA-1996-N-0028,"Tab 2 - ""Review of AHP Monograph Development Process"" - [American Herbal Pharmacopeia - Comment] - re FDA-1996-N-0028-0383",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-09T05:00:00Z,2008,12,,,2009-10-29T19:13:46Z,,0,0,09000064804fbbe4
FDA-1996-N-0028-0354,FDA,FDA-1996-N-0028,"Exhibit 3 - CDC, Food-Related Illness and Death in the United States - [Essential Nutrition, Ltd. et al - Comment] re FDA-1996-N-0028-0353",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-05T05:00:00Z,2008,12,,,2009-10-28T23:33:55Z,,0,0,09000064804fbb59
FDA-1996-N-0028-0355,FDA,FDA-1996-N-0028,"Exhibit 1 - CGMP Economic Impact Assessment - [Essential Nutrition, Ltd. et al - Comment] re FDA-1996-N-0028-0353",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-05T05:00:00Z,2008,12,,,2009-10-28T23:35:02Z,,0,0,09000064804fbb5f
FDA-1996-N-0028-0323,FDA,FDA-1996-N-0028,"Tab 7 - ""Appendix One"" - [ALI, American Labs., Inc. - Comment] re FDA-1996-N-0028-0310]",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:35:53Z,,0,0,09000064804fbafb
FDA-1996-N-0028-0324,FDA,FDA-1996-N-0028,"Tab 8 - ""Appendix Two"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:36:46Z,,0,0,09000064804fbafd
FDA-1996-N-0028-0320,FDA,FDA-1996-N-0028,"Tab 4 - ""SubParts B, C and D"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:30:47Z,,0,0,09000064804fbaf5
FDA-1996-N-0028-0328,FDA,FDA-1996-N-0028,"Tab 15 - ""BSE Test"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:53:45Z,,0,0,09000064804fbade
FDA-1996-N-0028-0325,FDA,FDA-1996-N-0028,"Tab 12 - ""21 CFR Part 111"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:38:00Z,,0,0,09000064804fbad3
FDA-1996-N-0028-0329,FDA,FDA-1996-N-0028,"Tab 10 - ""Data Tables"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:45:15Z,,0,0,09000064804fbae6
FDA-1996-N-0028-0321,FDA,FDA-1996-N-0028,"Tab 5 - ""Part E: Production & Process Controls"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:32:25Z,,0,0,09000064804fbaf7
FDA-1996-N-0028-0330,FDA,FDA-1996-N-0028,"Tab 9 - ""Memorandum, August 5, 2003"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:40:11Z,,0,0,09000064804fbaff
FDA-1996-N-0028-0326,FDA,FDA-1996-N-0028,"Tab 11 - ""References for FDA Guidance Inclusions"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:43:20Z,,0,0,09000064804fbad6
FDA-1996-N-0028-0331,FDA,FDA-1996-N-0028,"Tab 13 - ""Guidance 50244 (Federal Register Vol. 63, No. 182, Monday, September 21, 1998, Notices)"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:49:15Z,,0,0,09000064804fbb01
FDA-1996-N-0028-0327,FDA,FDA-1996-N-0028,"Tab 14 - ""Guidance FR 51074 (Federal Register Vol. 63, No. 185, Thursday, September 24, 1998 /Notices)"" - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:50:23Z,,0,0,09000064804fbad9
FDA-1996-N-0028-0322,FDA,FDA-1996-N-0028,"Tab 6 - ""Parts F, G, and H - [American Labs., Inc. (ALI) - Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-12-03T05:00:00Z,2008,12,,,2009-10-21T00:33:25Z,,0,0,09000064804fbaf9
FDA-1996-N-0028-0317,FDA,FDA-1996-N-0028,"Tab 1 - ""Introduction (No Material Submitted)"" - [American Labs., Inc. (ALI) – Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-11-10T05:00:00Z,2008,11,,,2009-10-21T00:22:59Z,,0,0,09000064804fbaee
FDA-1996-N-0028-0318,FDA,FDA-1996-N-0028,"Tab 2 - ""Preamble Changes and Comments"" - [ALI, American Labs., Inc. - Comment] re FDA-1996-N-0028-0310]",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-11-10T05:00:00Z,2008,11,,,2009-09-11T23:25:04Z,,0,0,09000064804fbaf1
FDA-1996-N-0028-0319,FDA,FDA-1996-N-0028,"Tab 3 - ""Part A General Provisions"" - [American Labs., Inc. (ALI) – Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,M-Memorandum (Supporting and Related Material),2008-11-10T05:00:00Z,2008,11,,,2009-10-21T00:28:58Z,,0,0,09000064804fbaf3
FDA-1996-N-0028-0315,FDA,FDA-1996-N-0028,"Table of Contents - [American Labs., Inc. (ALI) – Comment] re FDA-1996-N-0028-0310",Supporting & Related Material,C-Comment (Supporting and Related Material),2008-10-14T04:00:00Z,2008,10,,,2009-10-21T00:18:03Z,,0,0,09000064804fbae4
FDA-1996-N-0028-0291,FDA,FDA-1996-N-0028,American Herbal Products Association (AHPA) - Extension of Comment Request,Other,EXT-Request for Extension Comment Due Date,2008-10-06T04:00:00Z,2008,10,2008-10-06T04:00:00Z,1997-05-08T03:59:59Z,2013-07-27T21:18:16Z,,0,0,09000064804fba96
FDA-1996-N-0028-0293,FDA,FDA-1996-N-0028,Utah Natural Products Alliance - Request for Extension of Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-10-06T04:00:00Z,2008,10,2003-03-13T05:00:00Z,2003-06-12T03:59:59Z,2013-07-27T21:18:16Z,,0,0,09000064804fba94
FDA-1996-N-0028-0281,FDA,FDA-1996-N-0028,See FDA-1996-N-0028-0674,Supporting & Related Material,EMC-E-Mail  (Supporting and Related Material),2008-10-01T04:00:00Z,2008,10,,,2012-03-24T19:28:37Z,,0,0,09000064804fba4f
FDA-1996-N-0028-0280,FDA,FDA-1996-N-0028,See FDA-1996-N-0028-0673,Supporting & Related Material,EMC-E-Mail  (Supporting and Related Material),2008-10-01T04:00:00Z,2008,10,,,2012-03-24T19:34:50Z,,0,0,09000064804fba4d
FDA-1996-N-0028-0279,FDA,FDA-1996-N-0028,See FDA-1996-N-0028-0278,Supporting & Related Material,,2008-09-29T00:00:00Z,2008,9,,,2012-03-24T19:30:24Z,,0,1,09000064804fba33
FDA-1996-N-0028-0265,FDA,FDA-1996-N-0028,"FDA/CFSAN Division of Dietary Supplement Programs and Compliance, Office of Nutritional Products, Labeling and Dietary Supplements to the Dockets Management Branch, May 6. 2003 (re Development of Strategy for Dietary Supplements) - Memorandum",Other,M-Memorandum,2008-08-26T04:00:00Z,2008,8,2008-08-26T04:00:00Z,,2013-08-11T04:13:23Z,,0,0,09000064804fb9c9
FDA-1996-N-0028-0263,FDA,FDA-1996-N-0028,Council for Responsible Nutrition (CRN) - Request for Extension of Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-08-25T04:00:00Z,2008,8,2003-03-13T05:00:00Z,2003-06-12T03:59:59Z,2013-08-11T02:39:48Z,,0,0,09000064804fb9ba
FDA-1996-N-0028-0254,FDA,FDA-1996-N-0028,See FDA-1996-N-0028-0549,Supporting & Related Material,EMC-E-Mail  (Supporting and Related Material),2008-08-21T04:00:00Z,2008,8,,,2012-03-24T19:33:43Z,,0,0,09000064804fb991
FDA-1996-N-0028-0253,FDA,FDA-1996-N-0028,"American Herbal Products Association, National Nutritional Foods Association, and Utah Natural Product's Alliance (Kleinfeld, Kaplan, and Becker, LLP) - Request for Extension of Comment Due Date",Other,EXT-Request for Extension Comment Due Date,2008-08-21T04:00:00Z,2008,8,2003-03-13T05:00:00Z,2003-06-12T03:59:59Z,2013-07-27T21:18:15Z,,0,0,09000064804fb98d
FDA-1996-N-0028-0252,FDA,FDA-1996-N-0028,See FDA-1996-N-0028-0550,Supporting & Related Material,EMC-E-Mail  (Supporting and Related Material),2008-08-20T04:00:00Z,2008,8,,,2012-03-24T19:34:50Z,,0,0,09000064804fb981
FDA-1996-N-0028-0238,FDA,FDA-1996-N-0028,"Dietary Supplement Good Manufacturing Practices Small Business Outreach, July 12, 1999 re FDA-1996-N-0028-0007 - Transcript",Other,TR-Transcript,2008-08-12T04:00:00Z,2008,8,2008-08-12T04:00:00Z,,2013-07-27T21:18:14Z,,0,0,09000064804fb8a2
FDA-1996-N-0028-0240,FDA,FDA-1996-N-0028,"Small Business Outreach Meeting ""Current Good Manufacturing Practices in the Dietary Supplement Industry,"" October 21, 1999,  re FDA-1996-N-0028-0008 - Transcript",Other,TR-Transcript,2008-08-12T04:00:00Z,2008,8,2008-08-12T04:00:00Z,,2009-09-24T05:00:05Z,,0,0,09000064804fb8b0
FDA-1996-N-0028-0242,FDA,FDA-1996-N-0028,See FDA-1996-N-0028-0551,Supporting & Related Material,EMC-E-Mail  (Supporting and Related Material),2008-08-12T04:00:00Z,2008,8,,,2012-03-24T19:36:41Z,,0,0,09000064804fb8bc
FDA-1996-N-0028-0239,FDA,FDA-1996-N-0028,"Small Business Outreach Meeting ""Current Good Manufacturing Practices in the Dietary Supplement Industry,"" September 28, 1999,  re FDA-1996-N-0028-0008 - Transcript",Other,TR-Transcript,2008-08-12T04:00:00Z,2008,8,2008-08-12T04:00:00Z,,2013-07-27T21:18:14Z,,0,0,09000064804fb8af
FDA-1996-N-0028-0226,FDA,FDA-1996-N-0028,"A.F.A. (Aphanizomenon Flos Aquae), Inc. -  [Amended Comment (C45)] - Correction",Other,CR-Correction,2008-08-11T04:00:00Z,2008,8,2008-08-11T04:00:00Z,,2013-08-11T04:13:23Z,,0,0,09000064804fb89c
FDA-1996-N-0028-0185,FDA,FDA-1996-N-0028,"Reference 1 - ""Memorandum of Meeting, November 30,1995"" - [Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements - Advance Notice of Proposed Rulemaking] - Background Material re FDA-1996-N-0028-0001",Supporting & Related Material,BKG-Background Material,2008-08-04T18:44:35Z,2008,8,,,2009-09-23T18:44:39Z,,0,0,09000064806a78c1
FDA-1996-N-0028-0186,FDA,FDA-1996-N-0028,"Reference 2 - ""Discussion Draft of GMP's - November 21, 1995"" - [Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements - Advance Notice of Proposed Rulemaking] - Background Material re FDA-1996-N-0028-0001",Supporting & Related Material,BKG-Background Material,2008-08-04T18:42:49Z,2008,8,,,2009-09-23T18:42:58Z,,0,0,09000064806a790c
FDA-1996-N-0028-0176,FDA,FDA-1996-N-0028,Council for Responsible Nutrition (CRN) - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-08-04T04:00:00Z,2008,8,2008-08-04T04:00:00Z,1997-05-08T03:59:59Z,2013-07-27T21:18:14Z,,0,0,09000064804fb7ea
FDA-1996-N-0028-0187,FDA,FDA-1996-N-0028,"Reference 3 - ""FDA Procedures for Safe and Sanitary Processing and Importing of Fish and Fishery Products,"" Final Rule, 60 FR 65096, December 18, 1995"" - [Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements - Advance Notice of Proposed Rulemaking] - Background Material re FDA-1996-N-0028-0001",Supporting & Related Material,BKG-Background Material,2008-08-04T04:00:00Z,2008,8,,,2009-09-23T18:45:22Z,,0,0,09000064806a7a01
FDA-1996-N-0028-0177,FDA,FDA-1996-N-0028,"Hoffmann-La Roche Vitamins, Inc. - Request for Extension Comment Due Date",Other,EXT-Request for Extension Comment Due Date,2008-08-04T04:00:00Z,2008,8,2008-08-04T04:00:00Z,1997-05-08T03:59:59Z,2013-07-27T21:18:14Z,,0,0,09000064804fb7f0
FDA-1996-N-0028-0188,FDA,FDA-1996-N-0028,"Reference 4 - ""FDA Food and Safety Assurance Program; -“Development of Hazard Analysis-Critical ‘Control Points for the Food Industry,” Proposed RuIe, 59 FR 39888, August 4, 1994"" - [Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements - Advance Notice of Proposed Rulemaking] - Background Material re FDA-1996-N-0028-0001",Supporting & Related Material,BKG-Background Material,2008-08-04T04:00:00Z,2008,8,,,2009-09-23T18:47:32Z,,0,0,09000064806a7a2d
FDA-1996-N-0028-0180,FDA,FDA-1996-N-0028,Perrigo Company - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-08-04T04:00:00Z,2008,8,2008-08-04T04:00:00Z,1997-05-08T03:59:59Z,2013-08-11T04:13:23Z,,0,0,09000064804fb808
FDA-1996-N-0028-0174,FDA,FDA-1996-N-0028,Nutritional Health Alliance (NHA) - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-08-01T04:00:00Z,2008,8,2008-08-01T04:00:00Z,1997-05-08T03:59:59Z,2013-07-27T21:18:14Z,,0,0,09000064804fb7e0
FDA-1996-N-0028-0171,FDA,FDA-1996-N-0028,FDA Response Letter to the Honorable Michael Bilirakis (CI) - Answer,Other,ANS-Answer,2008-08-01T04:00:00Z,2008,8,2008-08-01T04:00:00Z,1997-05-08T03:59:59Z,2013-07-27T21:18:14Z,,0,0,09000064804fb7d2